MMP9 and psoriasis: Recent studies have indicated that unbound bilirubin (UCB) and its derivative dimethyl ester bilirubin (BD1) effectively inhibit the neutrophil-mediated activity of MMP-9 while reducing proinflammatory cytokine gene expression and modulating MAPK pathway signaling to alleviate psoriasis-like skin inflammation in mice (69).